Our findings confirmed that IGF1 administration could enhance the tumor growth of EphA4‐deleted mice up to a level similar to that observed in control WT mice, but could not enhance the metastatic tumor foci of EphA4‐deleted mice up to the WT level. This evidence concerns the gene EPHA4 and neoplasm.